DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

clinical trial

Details

Instance of: clinical trial
Start time: 8 May 2014
End time: April 2016
Country: United States
Main subject: psoriasis
clinical trial phase: phase II clinical trial
maximum age: 90
minimum age: 18
number of participants: 50
research intervention: clobetasol
research site: Radiant Research (United States), Lynn Health Science Institute
research subject recruitment status: completed
short name: HPA axis
study type: interventional study
title: A Randomized, Open Label, Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption With DFD-06 Cream Versus Clobetasol Propionate Cream, 0.05% in Subjects With Moderate to Severe Plaque Psoriasis

Nothing in the MetaHistoryBook collection references this item yet.